The toxicity and neuropathology of 2,4,5-tribromoimidazole and its derivatives in rats.
2,4,5-tribromoimidazole and its 1-n-butylcarboxylate and 1-dimethylcarbamoyl derivatives, when administered to rats, induced poisoning typical of uncouplers of oxidative phosphorylation. At 48 h rats surviving a single toxic dose of 20-60 mg/kg developed permanent incoordination of the hindlimbs in the absence of brain oedema. Neuropathologic examination of brain and spinal cord from perfused fixed rats at 24 h revealed neuronal necrosis and chromatolysis in the vestibular nucleus, the outer parietal neocortex and red nucleus. Chromatolysis and necrosis in these areas had increased at 72-96 h and were also observed in the deeper layers of the neocortex, the medial entorhinal cortex, the reticular formation, the grey matter of the spinal cord extending into the ventral horns, the dorsal, and ventral cochlear nuclei and the deep cerebellar nuclei, in decreasing order of severity. Neuronal necrosis was accompanied by an increased glial response, including neuronophagia and at 16 days with astroglial hypertrophy and hyperplasia.
D000284:Administration, Oral; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000473:pathology; D005260:Female; D007093:Imidazoles / Q000633:toxicity*; D007275:Injections, Intravenous; D007928:Lethal Dose 50; D009474:Neurons / Q000187:drug effects* / Q000473:pathology; D051381:Rats; D013116:Spinal Cord / Q000187:drug effects* / Q000473:pathology
D007093:Imidazoles; C045040:2,4,5-tribromoimidazole-1-n-butylcarboxylate; C045039:2,4,5-tribromoimidazole; C045041:2,4,5-tribromoimidazole-1-dimethylcarbamic acid